Shopping Cart
Remove All
Your shopping cart is currently empty
PARP1-IN-50
Catalog No. T214578 Copy Product Info
🥰Excellent
PARP1-IN-50 is a selective, orally active PARP-1 inhibitor with an IC50 of 64.98 nM. It inhibits PAR formation and induces DNA double-strand breaks, resulting in DNA damage. PARP1-IN-50 can cause G2/M phase arrest and apoptosis (apoptosis) in cancer cells, demonstrating significant antiproliferative activity against various cancer cell lines. This compound is useful in cancer research, including studies on breast cancer.
PARP1-IN-50
Copy Product Info🥰Excellent
Catalog No. T214578
PARP1-IN-50 is a selective, orally active PARP-1 inhibitor with an IC50 of 64.98 nM. It inhibits PAR formation and induces DNA double-strand breaks, resulting in DNA damage. PARP1-IN-50 can cause G2/M phase arrest and apoptosis (apoptosis) in cancer cells, demonstrating significant antiproliferative activity against various cancer cell lines. This compound is useful in cancer research, including studies on breast cancer.
PARP1-IN-50
Cas No. 2255341-36-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | PARP1-IN-50 is a selective, orally active PARP-1 inhibitor with an IC50 of 64.98 nM. It inhibits PAR formation and induces DNA double-strand breaks, resulting in DNA damage. PARP1-IN-50 can cause G2/M phase arrest and apoptosis (apoptosis) in cancer cells, demonstrating significant antiproliferative activity against various cancer cell lines. This compound is useful in cancer research, including studies on breast cancer. |
| Targets&IC50 | PARP1:64.98 nM |
| In vitro | PARP1-IN-50 (Compound 13) demonstrates significant antiproliferative activity in HCC-1937, Capan-1, MCF-7, and PANC-1 cells, with IC50 values of 0.88, 0.56, 4.49, and 1.53 μM, respectively. In HCC-1937 cells, PARP1-IN-50 (1-10 μM, 48 h) induces G2/M phase arrest and decreases the expression levels of CDK1 and cyclin B. Additionally, PARP1-IN-50 (1-10 μM, 4 h) inhibits H2O2-induced PAR formation in HCC-1937 cells. It also enhances PARP-1-DNA trapping and induces DNA double-strand breaks within 30 minutes at concentrations of 1-10 μM. Furthermore, treatment with PARP1-IN-50 (1-10 μM, 48 h) results in apoptosis in HCC-1937 cells. |
| In vivo | PARP1-IN-50 (Compound 13), administered orally at a dose of 25-50 mg/kg once daily for 21 days, significantly inhibits the growth of HCC-1937 xenograft tumors in BALB/c nude mice and demonstrates favorable safety characteristics. |
| Molecular Weight | 662.42 |
| Formula | C22H26Br2N6O4S2 |
| Cas No. | 2255341-36-5 |
| Smiles | S=C(N)NN=CC1=CC(Br)=C(OCCCCOC2=C(Br)C=C(C=NNC(=S)N)C=C2OC)C(OC)=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy PARP1-IN-50 | purchase PARP1-IN-50 | PARP1-IN-50 cost | order PARP1-IN-50 | PARP1-IN-50 in vivo | PARP1-IN-50 in vitro | PARP1-IN-50 formula | PARP1-IN-50 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.